crohn-s-disease

Documents about crohn-s-disease

• Evaluation of Urinary Isoprostanes in the Assessment of Children With Inflammatory Bowel Disease#1048011ClinicalTrials.gov
• Efficacy Classification Prediction of the Effects of Acupuncture on Abdominal Pain in Patients With Crohn's Disease#876023ClinicalTrials.gov
• A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease#895215ClinicalTrials.gov
• Anti-TNF Agents Restrict Adherent-invasive Escherichia coli Replication Within Macrophages Through Modulation of Chitinase 3-like 1 in Patients with Crohn’s Disease#670238HAL (France)
• Vitamin D Levels in Children With IBD#846454ClinicalTrials.gov
• Medication Adherence in Patients With Inflammatory Bowel Disease (IBD)#896693ClinicalTrials.gov
• Acceptance and Commitment Therapy (ACT) in Inflammatory Bowel Disease#895275ClinicalTrials.gov
• Data Management and Sharing Plan for: Cellular biomarkers for pediatric Crohn's disease#278285UNC Dataverse Dataverse OAI Archive
• The Influence of Hyperbaric Oxygen in Patients With Perianal Crohn's Disease Already Treated With TNF Alpha Blockers Treated With TNF Alpha Blockers#800470ClinicalTrials.gov
• A Phase I Study of Etrolizumab Followed by Open-Label Extension and Safety Monitoring in Pediatric Patients With Moderate to Severe Ulcerative Colitis or Moderate to Severe Crohn's Disease#834722ClinicalTrials.gov
• A Study to Test Efficacy, Safety, and Pharmacokinetics of Certolizumab Pegol in Children and Adolescents With Moderately to Severely Active Crohn's Disease#872972ClinicalTrials.gov
• İnflamatuvar barsak hastalığı olanlarda nütrisyonel durumun değerlendirilmesinde ultrasonografi ile ölçülen temporal kas kalınlığının kullanılması#1067631Recep Tayyip Erdoğan University Institutional Repository
• Disrupted Functional Network Organization in Crohn's Disease: Interoceptive Alterations Linked to Anxiety.#625838NCBI PubMed Central
• Multiomics integration and machine learning reveal colony stimulating factor 3 receptor as a key gene and therapeutic target in Crohn’s disease#377558DR-NTU (Digital Repository of NTU)
• An Assessment of Goal-Directed Intraoperative Fluid Management in Hand Assisted Laparoscopic Colectomy#834742ClinicalTrials.gov
• Narrow Band Imaging Versus Artificial Intelligence for Colonic Surveillance in Inflammatory Bowel Disease#870491ClinicalTrials.gov
• QiC3: A novel automated quantitative immunohistological disease activity index for ileocolonic Crohn's disease and ulcerative colitis#349782bioRxiv / medRxiv
• A Study of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease#869500ClinicalTrials.gov
• Role of Capsule Endoscopy in the Evaluation of Mucosal Changes During Treatment of Patients With Active Crohn's Disease#843970ClinicalTrials.gov
• Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease#674855ClinicalTrials.gov
• A follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425]#831919ClinicalTrials.gov
• Tracking the Natural Course of Silent Small Bowel Narrowing in Adults With Crohn's Disease#846315ClinicalTrials.gov
• E-nose in Evaluating Colitis Activity#862962ClinicalTrials.gov
• Endomicroscopy in IBD Patients#896256ClinicalTrials.gov
• Does Clinical Response Correlate With Serum Certolizumab Levels?#916394ClinicalTrials.gov
• Mesentery Guide Identify Microscopic Clean Resection and Reduces Crohn's Endoscopic Recurrence#831455ClinicalTrials.gov
• Centocor Microarray Study of Patients#916521ClinicalTrials.gov
• A clinical decision support tool may help to optimise vedolizumab therapy in Crohn's disease#172990HAL (France)
• A Study of the Efficacy and Safety of Upadacitinib in Participants With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional and/or Biologic Therapies#835768ClinicalTrials.gov
• Dose-escalating Therapeutic Study of Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Fistulas in Patients With Refractory Perianal Crohn's Disease#868222ClinicalTrials.gov
• Can Vitamin D Replacement Correct Chronic Disease Anemia?#917800ClinicalTrials.gov
• DWI MR-enterography Without or With Bowel Cleansing to Assess Intestinal Inflammatory Activity in the Follow-up of Crohn's Disease#839842ClinicalTrials.gov
• Generative AI-augmented transcriptomic and microbiome analysis across inflammatory and fibrotic disease states in Crohn's disease.#469120NCBI PubMed Central
• A Trial of Iron Replacement in Patients With Iron Deficiency.#840202ClinicalTrials.gov
• Based on the Special Disease Management of Crohn's Disease Diet Studies#881409ClinicalTrials.gov
• Improving the Quality of Care for Adults With Inflammatory Bowel Disease#966784ClinicalTrials.gov
• Treatment of Iron Deficiency Anaemia in Inflammatory Bowel Disease With Ferrous Sulphate#969505ClinicalTrials.gov
• Neglected kingdoms: the gut virome, mycobiome and their role in inflammatory bowel disease#4491Europe PMC
• Acceptability and tolerability of risankizumab maintenance therapy administered via on-body injector in patients with Crohn’s disease: Results of the ACCEPT-OBI study#796319HAL (France)
• An Open-Label Extension and Long-term Efficacy and Safety Monitoring Study of Patients with Crohn's Disease Previously Included in the Loss of RESponse to Ustekinumab Treated by Dose Escalation Study#898296ClinicalTrials.gov
• Psychological distress links to magnetic resonance enterography abnormalities in Crohn's disease.#125618NCBI PubMed Central
• Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.#836666ClinicalTrials.gov
• Data Sheet 1_Baseline gut microbiome features associated with fecal calprotectin response to exclusive enteral nutrition in pediatric Crohn’s disease.zip#266418Figshare
• Guideline review: 2025 British Society of Gastroenterology guidelines on inflammatory bowel disease in adults – Part 1: Crohn’s disease#276048PubMed Central
• A Randomized Crossover Trial of Bright Light Therapy in Crohn's Disease on Intestinal Barrier Homeostasis#801716ClinicalTrials.gov
• Colesevelam for the Treatment of Bile Acid Malabsorption in Patients With Crohn's Disease#868509ClinicalTrials.gov
• Oral N-acetylglucosamine in Crohn's Disease#982102ClinicalTrials.gov
• Iron Supplementation in Inflammatory Bowel Disease (IBD) Patients With Chronic Fatigue#803546ClinicalTrials.gov
• SC12267 (4SC-101) for Treatment of Patients With Inflammatory Bowel Disease#830661ClinicalTrials.gov
• A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of ABT-494 for the Induction of Symptomatic and Endoscopic Remission in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Immunomodulators or Anti-TNF Therapy#325297ClinicalTrials.gov